Blends
KLOW
About This Compound
KLOW
KLOW 80mg — Research Overview
KLOW is a proprietary research blend combining four extensively studied peptides in a single lyophilized formulation, examined in laboratory environments for tissue repair, cellular regeneration, angiogenesis, skin biology, and immune modulation pathways.
Compound Profile
- TB-500 (10mg) — Thymosin Beta-4 fragment; actin-binding, cell migration, and systemic tissue repair pathway research
- BPC-157 (10mg) — Body Protection Compound; local tissue repair, angiogenesis (VEGF), and gastroprotective pathway research
- GHK-Cu (50mg) — Copper peptide; collagen synthesis, fibroblast activation, and extracellular matrix remodeling research
- KPV (10mg) — Alpha-MSH C-terminal tripeptide; anti-inflammatory signaling, NF-kB inhibition, and gut barrier research
What Researchers Study KLOW For
- Multi-Pathway Tissue Repair — simultaneous local (BPC-157) and systemic (TB-500) repair mechanism studies
- Collagen and Matrix Remodeling — GHK-Cu fibroblast stimulation and extracellular matrix production pathway research
- Immune Modulation — KPV anti-inflammatory signaling and NF-kB pathway studies
- Angiogenesis Research — VEGF pathway activation and vascular formation studies
- Skin Biology — combined GHK-Cu and BPC-157 dermal repair and regeneration pathway research
- Gut Barrier Research — KPV and BPC-157 combined gastrointestinal mucosal integrity studies
Frequently Asked Questions
What is KPV and how does it complement the other components?
KPV (Lys-Pro-Val) is the C-terminal tripeptide of alpha-melanocyte-stimulating hormone. It is studied for anti-inflammatory properties including NF-kB pathway inhibition and cytokine modulation. In KLOW, KPV addresses the inflammatory signaling dimension, complementing TB-500 and BPC-157 structural repair activities and GHK-Cu matrix remodeling effects.
Why are TB-500 and BPC-157 combined in research blends?
TB-500 operates primarily through systemic actin regulation and cell migration signaling, while BPC-157 acts locally at the site of tissue injury through VEGF and angiogenic pathways. Their complementary mechanisms make them one of the most studied peptide combinations in regenerative research.
What reconstitution approach is standard?
Lyophilized KLOW is typically reconstituted with bacteriostatic water. Store at or below 4°C and use within 28 days. Store lyophilized powder at 2-8°C prior to reconstitution.
Is a Certificate of Analysis included?
Yes. Every vial ships with a third-party COA confirming blend composition, purity (≥99% HPLC for each component), and peptide integrity.